Pseudomonas aeruginosa Antimicrobial Susceptibility Results at a State Hospital in Turkey (2010-2016)

Şafak, Birol; Kilinç, Osman; Tunç, Nedim; Topçu, Birol

doi:10.5222/ankem.2018.031

Cited by 1 publication

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In another study published in 2018, Şafak et al reported that amikacin and colistin were the most effective antibiotics in inpatients. 34 Santos et al found colistin resistance of 3.89% in 62 clinical P. aeruginosa isolates. 35 Colistin resistance has come to the fore with the addition of polymyxin group antibiotics to the treatment list, as a result of the development of P. aeruginosa resistance to many other antibiotics in recent years.…”

Section: Discussionmentioning

confidence: 99%

Investigation of Virulence Factors and Antibiotic Resistance of Pseudomonas aeruginosa Isolated from A Range of Clinical Samples

ÖZKAN,

BUDAK

2023

Kocaeli Üniversitesi Sağlık Bilimleri Dergisi

View full text Add to dashboard Cite

Objective: Pseudomonas aeruginosa is an opportunistic pathogen, is one of the leading nosocomial infection-causing agents and over time has developed multidrug resistance. One of the most common patient groups affected by P. aeruginosa are on the intensive care unit (ICU), an optimal environment for the development of antibiotic resistance. The aim of this study was to investigate virulence factors and antibiotic resistance profiles of P. aeruginosa isolated from hospitalized patients in Turkey. Methods: Samples from the general wards and ICU-hospitalized patients were included. A nutrient agar-elastin method was used for the biochemical activity of elastase. For las B assessment PCR was used while special production medium was used to assay pyoverdine and pyocyanin. Isolate biofilm production was tested with the crystal violet method. Standard broth microdilution was used for antibiotic susceptibility. Results: A total of 208 samples were assessed. The virulence factor frequencies in ICU and ward isolates, were: pyocyanin 86.2% and 86.7%, pyoverdine 90.1%, and 89.6%, elastase 68.6% and 67.9%, las B 93.1% and 89.6%, and biofilm production 51.9% and 48.1%, respectively. Antibiotic resistance rates in ICU and ward were: meropenem 41.1% and 28.9%, colistin 11.7% and 13.2%, ceftazidime 43.1%,and 41.1%, and cefepime 52.9% and 48.5%. Conclusion: Virulence factors were present in most of the hospitalized patient samples. However, antibiotic resistance rates were below 50%, except for cefepime. In addition, low rates of colistin resistance suggest that colistin resistance is not yet widespread in our hospital.

show abstract

Section: Discussionmentioning

confidence: 99%